PharmaShots | Incisive News in 3 Shots

Subscribe Now

ALK-Positive Anaplastic Large Cell Lymphoma

Pfizer's Xalkori (crizotinib) Receives the US FDA's Approval for ALK-Positive Anaplastic Large Cell Lymphoma In Children And Young Adults

Pfizer's Xalkori (crizotinib) Receives the US FDA's Approval for ALK-Positive Anaplastic Large Cell Lymphoma In Children And Young...

January 15, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us